T lymphocytes to predict radiation-induced late effects in normal tissues

References

• Ward JF. DNA damage as the cause of ionizing radiation-induced gene activation. Radiat Res. 1994;138(1 Suppl):S85–88.
   PubMed Web of Science ®Google Scholar
• Bonnaud S, Niaudet C, Pottier G, et al. Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res. 2007;67(4):1803–1811.
   PubMed Web of Science ®Google Scholar
• Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23(5):687–696.
   PubMed Web of Science ®Google Scholar
• Vieillot S, Fenoglietto P, Moscardo C-L, et al. [Which intensity modulated radiation therapy? From “step and shoot” to volumetric modulated arc therapy, point of view of the radiation oncologist]. Cancer Radiother J Soc Francaise Radiother Oncol. 2010;14(6–7):550–553.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10–19.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Rosenstein BS, Kerns SL, et al. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2016. pii: S0167–8140(16)31177-X. doi: 10.1016/j.radonc.2016.06.017. [Epub ahead of print].
   Google Scholar
• Kerns SL, Dorling L, Fachal L, et al. Meta-analysis of genome wide association studies identifies genetic markers of late toxicity following radiotherapy for prostate cancer. EBioMedicine. 2016;10:150–163.
   PubMed Web of Science ®Google Scholar
• Barnett GC, Coles CE, Elliott RM, et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol. 2012;13(1):65–77.
   PubMed Web of Science ®Google Scholar
• Barnett GC, Kerns SL, Noble DJ, et al. Incorporating genetic biomarkers into predictive models of normal tissue toxicity. Clin Oncol. 2015;27(10):579–587.
   Web of Science ®Google Scholar
• Kerns SL, Kundu S, Oh JH, et al. The prediction of radiotherapy toxicity using single nucleotide polymorphism-based models: a step toward prevention. Semin Radiat Oncol. 2015;25(4):281–291.
   PubMed Web of Science ®Google Scholar
• Kerns SL, West CML, Andreassen CN, et al. Radiogenomics: the search for genetic predictors of radiotherapy response. Future Oncol Lond Engl. 2014;10(15):2391–2406.
   PubMed Web of Science ®Google Scholar
• Stone HB, Coleman CN, Anscher MS, et al. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529–536.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Thames HD, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol J Eur Soc Ther Radiol Oncol. 1989;15(3):267–274.
   PubMed Web of Science ®Google Scholar
• Dörr W. Radiobiology of tissue reactions. Ann ICRP. 2015;44(1 Suppl):58–68.
   PubMedGoogle Scholar
• Lartigau E, Dubray B, Mornex F. [Biological mechanisms of late effects of ionizing radiations]. Cancer Radiother J Soc Fr Radiother Oncol. 1997;1(6):669–676.
   PubMedGoogle Scholar
• Delanian S, Lefaix J-L. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007;17(2):99–107.
   PubMed Web of Science ®Google Scholar
• Jain M, Rivera S, Monclus EA, et al. Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling. J Biol Chem. 2013;288(2):770–777.
   PubMed Web of Science ®Google Scholar
• Richter K, Konzack A, Pihlajaniemi T, et al. Redox-fibrosis: impact of TGFβ1 on ROS generators, mediators and functional consequences. Redox Biol. 2015;6:344–352.
   PubMed Web of Science ®Google Scholar
• Taylor AM, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 1975;258(5534):427–429.
   PubMed Web of Science ®Google Scholar
• Tanteles GA, Murray RJS, Mills J, et al. Variation in telangiectasia predisposing genes is associated with overall radiation toxicity. Int J Radiat Oncol Biol Phys. 2012;84(4):1031–1036.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Overgaard J, Alsner J, et al. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64(3):776–783.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Alsner J, Overgaard M, et al. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM–a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol. 2006;82(8):577–586.
   PubMed Web of Science ®Google Scholar
• Burnet NG, Nyman J, Turesson I, et al. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet Lond Engl. 1992;339(8809):1570–1571.
   PubMed Web of Science ®Google Scholar
• Geara FB, Peters LJ, Ang KK, et al. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 1993;27(5):1173–1179.
   PubMed Web of Science ®Google Scholar
• Peacock J, Ashton A, Bliss J, et al. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2000;55(2):173–178.
   PubMed Web of Science ®Google Scholar
• Kaspler P, Chen R, Hyrien O, et al. Biodosimetry using radiation-induced micronuclei in skin fibroblasts. Int J Radiat Biol. 2011;87(8):824–838.
   PubMed Web of Science ®Google Scholar
• Oppitz U, Denzinger S, Nachtrab U, et al. Radiation-induced comet-formation in human skin fibroblasts from radiotherapy patients with different normal tissue reactions. Strahlenther Onkol Organ Dtsch Röntgenges Al. 1999;175(7):341–346.
   PubMed Web of Science ®Google Scholar
• Sasai K, Evans JW, Kovacs MS, et al. Prediction of human cell radiosensitivity: comparison of clonogenic assay with chromosome aberrations scored using premature chromosome condensation with fluorescence in situ hybridization. Int J Radiat Oncol Biol Phys. 1994;30(5):1127–1132.
   PubMed Web of Science ®Google Scholar
• COPERNIC project investigators, Granzotto A, Benadjaoud MA, et al. Influence of nucleoshuttling of the atm protein in the healthy tissues response to radiation therapy: toward a molecular classification of human radiosensitivity. Int J Radiat Oncol Biol Phys 2016;94(3):450–460.
   PubMed Web of Science ®Google Scholar
• Schaue D, McBride WH. T lymphocytes and normal tissue responses to radiation. Front Oncol. 2012;2:119.
   PubMedGoogle Scholar
• MacLennan IC, Kay HE. Analysis of treatment in childhood leukemia. IV. the critical association between dose fractionation and immunosuppression induced by cranial irradiation. Cancer. 1978;41(1):108–111.
   PubMed Web of Science ®Google Scholar
• Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011;11(3):221–230.
   PubMed Web of Science ®Google Scholar
• Pelus LM, Fukuda S. Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia. 2008;22(3):466–473.
   PubMed Web of Science ®Google Scholar
• Schmitz A, Bayer J, Déchamps N, et al. Intrinsic susceptibility to radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys. 2003;57(3):769–778.
   PubMed Web of Science ®Google Scholar
• Crompton NE, Miralbell R, Rutz HP, et al. Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys. 1999;45(3):707–714.
   PubMed Web of Science ®Google Scholar
• Crompton NE, Shi YQ, Emery GC, et al. Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys. 2001;49(2):547–554.
   PubMed Web of Science ®Google Scholar
• West CM, Elyan SA, Berry P, et al. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int J Radiat Biol. 1995;68(2):197–203.
   PubMed Web of Science ®Google Scholar
• Vandevoorde C, Depuydt J, Veldeman L, et al. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. Int J Radiat Biol. 2016;92(12):823–836.
   PubMed Web of Science ®Google Scholar
• Pinkawa M, Brzozowska K, Kriehuber R, et al. Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients. Future Oncol Lond Engl. 2016;12(5):617–624.
   PubMed Web of Science ®Google Scholar
• Azria D, Riou O, Castan F, et al. Radiation-induced CD8 T-lymphocyte apoptosis as a predictor of breast fibrosis after radiotherapy: results of the prospective multicenter french trial. EBioMedicine. 2015;2(12):1965–1973.
   PubMed Web of Science ®Google Scholar
• Ozsahin M, Crompton NEA, Gourgou S, et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(20):7426–7433.
   PubMed Web of Science ®Google Scholar
• Bordón E, Henríquez-Hernández LA, Lara PC, et al. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs). Radiat Oncol Lond Engl. 2010;5:4.
   PubMed Web of Science ®Google Scholar
• Bordón E, Henríquez-Hernández LA, Lara PC, et al. Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and Natural Killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients. Int J Radiat Biol. 2011;87(4):424–431.
   PubMed Web of Science ®Google Scholar
• Foro P, Algara M, Lozano J, et al. Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study. Int J Radiat Oncol Biol Phys. 2014;88(5):1057–1063.
   PubMed Web of Science ®Google Scholar
• Fuentes-Raspall MJ, Caragol I, Alonso C, et al. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism. Apoptosis Int J Program Cell Death. 2015;20(3):371–382.
   PubMed Web of Science ®Google Scholar
• Winkler S, Hoppe P, Haderlein M, et al. Ex vivo apoptosis in CD8+ lymphocytes predicts rectal cancer patient outcome. Gastroenterol Res Pract. 2016;2016:1–7.
   Web of Science ®Google Scholar
• Chua MLK, Somaiah N, A’Hern R, et al. Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2011;99(3):362–366.
   PubMed Web of Science ®Google Scholar
• van Oorschot B, Hovingh SE, Moerland PD, et al. Reduced activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation toxicity. Int J Radiat Oncol Biol Phys. 2014;88(3):664–670.
   PubMed Web of Science ®Google Scholar
• Brzozowska K, Pinkawa M, Eble MJ, et al. In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy. Int J Radiat Biol. 2012;88(5):405–413.
   PubMed Web of Science ®Google Scholar
• Greve B, Bölling T, Amler S, et al. Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison–lessons for future studies. Plos One. 2012;7(10):e47185.
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP, Keyes M. Residual gammaH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2008;86(3):336–346.
   PubMed Web of Science ®Google Scholar
• Werbrouck J, De Ruyck K, Beels L, et al. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity. Oncol Rep. 2010;23(2):571–578.
   PubMed Web of Science ®Google Scholar
• Scott D, Barber JB, Spreadborough AR, et al. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol. 1999;75(1):1–10.
   PubMed Web of Science ®Google Scholar
• Finnon P, Kabacik S, MacKay A, et al. Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2012;105(3):329–336.
   PubMed Web of Science ®Google Scholar
• Terzoudi GI, Hatzi VI, Barszczewska K, et al. G2-checkpoint abrogation in irradiated lymphocytes: a new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer. Int J Oncol. 2009;35(5):1223–1230.
   PubMed Web of Science ®Google Scholar
• Barber JB, Burrill W, Spreadborough AR, et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2000;55(2):179–186.
   PubMed Web of Science ®Google Scholar
• Padjas A, Kedzierawski P, Florek A, et al. Comparative analysis of three functional predictive assays in lymphocytes of patients with breast and gynaecological cancer treated by radiotherapy. J Contemp Brachytherapy. 2012;4(4):219–226.
   PubMed Web of Science ®Google Scholar
• McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat. 2006;100(2):229–235.
   PubMed Web of Science ®Google Scholar
• Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst. 2009;101(21):1446–1452.
   PubMed Web of Science ®Google Scholar
• Baeyens A, Thierens H, Claes K, et al. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer. 2002;87(12):1379–1385.
   PubMed Web of Science ®Google Scholar
• Hoeller U, Borgmann K, Bonacker M, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol. 2003;69(2):137–144.
   PubMed Web of Science ®Google Scholar
• Claes K, Depuydt J, Taylor AMR, et al. Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives. Neuromolecular Med. 2013;15(3):447–457.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang H, Iliakis G, et al. Caffeine-induced radiosensitization is independent of nonhomologous end joining of DNA double-strand breaks. Radiat Res. 2003;159(3):426–432.
   PubMed Web of Science ®Google Scholar
• Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8(12):957–967.
   PubMed Web of Science ®Google Scholar
• Kinner A, Wu W, Staudt C, et al. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008;36(17):5678–5694.
   PubMed Web of Science ®Google Scholar
• Rogakou EP, Boon C, Redon C, et al. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 1999;146(5):905–916.
   PubMed Web of Science ®Google Scholar
• Ivashkevich A, Redon CE, Nakamura AJ, et al. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett. 2012;327(1–2):123–133.
   PubMed Web of Science ®Google Scholar
• Ozsahin M, Ozsahin H, Shi Y, et al. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys. 1997;38(2):429–440.
   PubMed Web of Science ®Google Scholar
• Mirjolet C, Merlin JL, Dalban C, et al. Correlation between radio-induced lymphocyte apoptosis measurements obtained from two French centres. Cancer Radiother J Soc Fr Radiother Oncol. 2016;20(5):391–394.
   PubMed Web of Science ®Google Scholar
• Azria D, Belkacemi Y, Romieu G, et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol. 2010;11(3):258–265.
   PubMed Web of Science ®Google Scholar
• Bourgier C, Kerns S, Gourgou S, et al. Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2016;27(3):474–480.
   PubMed Web of Science ®Google Scholar
• Chua MLK, Horn S, Somaiah N, et al. DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy. Radiat Environ Biophys. 2014;53(2):355–364.
   PubMed Web of Science ®Google Scholar
• Barnett GC, West CML, Dunning AM, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 2009;9(2):134–142.
   PubMed Web of Science ®Google Scholar
• Bourgier C, Lacombe J, Solassol J, et al. Late side-effects after curative intent radiotherapy: identification of hypersensitive patients for personalized strategy. Crit Rev Oncol Hematol. 2015;93(3):312–319.
   PubMed Web of Science ®Google Scholar
• Azria D, Bourgier C, Brengues M. One size fits all: does the Dogma stand in radiation oncology? EBioMedicine. 2016;10:19–20.
   PubMed Web of Science ®Google Scholar
• Shiao SL, Coussens LM. The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia. 2010;15(4):411–421.
   PubMed Web of Science ®Google Scholar